Type 1 diabetes information Vacor was withdrawn from the U.S. market in 1979. The current remended goal for HbA1c in patients with diabetes is <7.0%, as defined as "good glycemic control", although some guidelines are stricter (<6.5%). Lack of insulin resistance, determined by a glucose tolerance test, would also be suggestive of Type 1. Some suggest that vitamin D3 may be an important pathogenic factor in type 1 diabetes independent of geographical latitude [7]. The liver is expected to be the most reasonable choice because it is more accessible than the pancreas and the Islet cells seem to produce insulin well in that environment. Type 1 diabetes information. Experimental replacement of beta cells (by transplant) is being investigated in several research programs and may bee clinically available in the future. For diabetes mellitus in pets, see diabetes in cats and dogs. The first goal can be achieved through close glycemic control (ie, blood glucose levels); the reduction effect in diabetic plications has been well demonstrated in several extensive clinical trials and is thus well established. This leads to substantially increased morbidity and mortality in both Type 1 and Type 2 patients, but the two have quite different origins and treatments despite the similarity in plications which often confuse even diabetics. Other pancreatic problems, including trauma, pancreatitis, or tumors (either malignant or benign), can also lead to loss of insulin production. Some chemicals and drugs specifically destroy pancreatic cells. Diabetes mellitus with a known etiology, such as secondary to other diseases, known gene defects, trauma or surgery, or the effects of drugs, is more appropriately called secondary diabetes mellitus. Vacor was withdrawn from the U.S. market in 1979. Type 1 diabetes information. Diabetic information book
Examples include diabetes mellitus caused by hemochromatosis, pancreatic insufficiency, or certain types of medications (e.g. long-term steroid use). Vacor (N-3-pyridylmethyl-N'-p-nitrophenyl urea), a rodenticide introduced in the United States in 1975, selectively destroys pancreatic beta cells, resulting in Type 1 diabetes after accidental or intentional ingestion. |